These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 21193853)

  • 1. Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
    Ittner LM; Götz J
    Nat Rev Neurosci; 2011 Feb; 12(2):65-72. PubMed ID: 21193853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Tau in Alzheimer's Disease.
    Ittner A; Ittner LM
    Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
    Pooler AM; Polydoro M; Wegmann SK; Pitstick R; Kay KR; Sanchez L; Carlson GA; Gomez-Isla T; Albers MW; Spires-Jones TL; Hyman BT
    J Comp Neurol; 2013 Dec; 521(18):4236-48. PubMed ID: 23839581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease.
    Goedert M; Sisodia SS; Price DL
    Curr Opin Neurobiol; 1991 Oct; 1(3):441-7. PubMed ID: 1821689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
    Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
    Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer's disease: a hypothesis.
    Braak H; Del Tredici K
    Acta Neuropathol; 2013 Aug; 126(2):303-6. PubMed ID: 23824268
    [No Abstract]   [Full Text] [Related]  

  • 10. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection.
    Adalbert R; Gilley J; Coleman MP
    Trends Mol Med; 2007 Apr; 13(4):135-42. PubMed ID: 17344096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
    Spires-Jones TL; Hyman BT
    Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
    Gallardo G; Holtzman DM
    Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Interaction between the β-Amyloid Core and Tau Facilitates Cross-Seeding: A Novel Target for Therapeutic Intervention.
    Tripathi T; Khan H
    Biochemistry; 2020 Feb; 59(4):341-342. PubMed ID: 31944100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 19. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic tau: A pathological or physiological phenomenon?
    Robbins M; Clayton E; Kaminski Schierle GS
    Acta Neuropathol Commun; 2021 Sep; 9(1):149. PubMed ID: 34503576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.